Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Study of Sorafenib Plus Toripalimab for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

NCT04069949 is registered in ClinicalTrials.gov with Sichuan University as lead sponsor.

NCT NCT04069949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04069949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Study of Sorafenib Plus Toripalimab for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Lead sponsor
Sichuan University
Phase
Phase 1/2
Overall status
Unknown status
Start date
December 1, 2019
Completion date
October 1, 2021
Enrollment
39 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

portal vein tumor thrombus, unresectable hepatocellular cancer